Compare · HDSN vs ZBH
HDSN vs ZBH
Side-by-side comparison of Hudson Technologies Inc. (HDSN) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- HDSN operates in Consumer Discretionary, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $17.63B, about 67.9x HDSN ($259.6M).
- Over the past year, HDSN is down 24.7% and ZBH is down 2.2% - ZBH leads by 22.5 points.
- ZBH has been more active in the news (11 items in the past 4 weeks vs 10 for HDSN).
- ZBH has more recent analyst coverage (25 ratings vs 11 for HDSN).
- Company
- Hudson Technologies Inc.
- Zimmer Biomet Holdings Inc.
- Price
- $6.18-2.06%
- $91.13-2.79%
- Market cap
- $259.6M
- $17.63B
- 1M return
- +11.05%
- +2.00%
- 1Y return
- -24.73%
- -2.18%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 10
- 11
- Recent ratings
- 11
- 25
Hudson Technologies Inc.
Hudson Technologies, Inc. a refrigerant services company, provides solutions to recurring problems within the refrigeration industry primarily in the United States. The company's products and services include refrigerant and industrial gas sales; refrigerant management services consisting primarily of reclamation of refrigerants, re-usable cylinder refurbishment, and hydrostatic testing services; and RefrigerantSide services comprising system decontamination to remove moisture, oils, and other contaminants. It also offers SmartEnergy OPS service, a web-based real time continuous monitoring service; and Chiller Chemistry and Chill Smart services. In addition, the company participates in the generation of carbon offset projects. It serves commercial, industrial, and governmental customers, as well as refrigerant wholesalers, distributors, contractors, and refrigeration equipment manufacturers. Hudson Technologies, Inc. was founded in 1991 and is headquartered in Pearl River, New York.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest HDSN
- Amendment: SEC Form SCHEDULE 13G/A filed by Hudson Technologies Inc.
- Large owner Hartree Partners, Lp bought $31,352 worth of shares (5,234 units at $5.99), increasing direct ownership by 0.11% to 4,976,536 units (SEC Form 4)
- Large owner Hartree Partners, Lp bought $4,477,207 worth of shares (764,202 units at $5.86), increasing direct ownership by 18% to 4,971,302 units (SEC Form 4)
- New insider Hartree Partners, Lp claimed ownership of 4,207,100 shares (SEC Form 3)
- Director Sheriff Alan was granted 3,219 shares, increasing direct ownership by 35% to 12,484 units (SEC Form 4)
- Director Prouty Eric A was granted 4,440 shares, increasing direct ownership by 3% to 158,292 units (SEC Form 4)
- SEC Form 4 filed by Director Parrillo Richard
- Director Mansy Loan Nguyen was granted 8,881 shares, increasing direct ownership by 35% to 34,476 units (SEC Form 4)
- SEC Form 4 filed by Director Bulgarino Nicole E
- Director Feeler Jeffrey R was granted 3,219 shares, increasing direct ownership by 35% to 12,384 units (SEC Form 4)
Latest ZBH
- Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
- Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
- BMO Capital Markets initiated coverage on Zimmer Biomet with a new price target
- SEC Form 4 filed by Director Hilado Maria Teresa
- SEC Form 4 filed by Director Kurdikar Devdatt
- SEC Form 4 filed by Director Hagemann Robert
- SEC Form 4 filed by Director Higgins Arthur J
- SEC Form 4 filed by Director Kolli Sreelakshmi
- SEC Form 4 filed by Director Farrell Michael J.
- SEC Form 4 filed by Director Shapiro Louis